Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
32 hedge funds and large institutions have $24.2M invested in Fibrocell Science Inc. in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
76% more call options, than puts
Call options by funds: $90K | Put options by funds: $51K
10% more funds holding
Funds holding: 29 → 32 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less capital invested
Capital invested by funds: $32.3M → $24.2M (-$8.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$154K |
| 2 |
FO
FT Options
Chicago,
Illinois
|
+$123K |
| 3 |
VF
Virtu Financial
New York
|
+$117K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$55.2K |
| 5 |
Renaissance Technologies
New York
|
+$34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$850K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$58.2K |
| 3 |
SCA
STALEY CAPITAL ADVISERS
Pittsburgh,
Pennsylvania
|
-$9.17K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7.02K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
26
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|
|
TWA
27
TCI Wealth Advisors
Tucson,
Arizona
| $1K | – | – | – |
|
|
KF
28
Krilogy Financial
St. Louis,
Missouri
| $1K | +$113 | +7 | +21% |
|
|
RE
29
RBC Europe
London,
United Kingdom
| $205 | +$210 | +13 | New |
|
30
BNP Paribas Financial Markets
Paris,
France
| $6 | – | – | – |
|
|
31
UBS Group
Zurich,
Switzerland
| – | -$7.02K | -434 | -98% |
|
|
32
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$2K | -109 | Closed |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$16 | +1 | New |
|
FCSC Hedge Fund Activity: Q3 2017 in Review
32 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q3 2017, worth a combined $24.2M — down 25% from $32.3M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new FCSC positions and 1 closed out — a net gain of 4 holders — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $154K. The largest seller was Fidelity Investments, cutting an estimated $850K.
- 32 institutional investors held Fibrocell Science Inc. (FCSC) as of Q3 2017, up from 29 in Q2 2017.
- Funds reported $24.2M of Fibrocell Science Inc. stock for Q3 2017, down 25% quarter-over-quarter.
- 5 funds opened new Fibrocell Science Inc. positions in Q3 2017 and 1 closed out, a net change of +4 holders.
- The largest Fibrocell Science Inc. buyer in Q3 2017 was Morgan Stanley, an estimated $154K added.
- The largest Fibrocell Science Inc. seller in Q3 2017 was Fidelity Investments, an estimated $850K sold.
Based on aggregated 13F filings for Q3 2017.